Clinical Trials Directory

Trials / Completed

CompletedNCT00780442

D-Cycloserine and Cue Exposure in Cocaine-Dependent Individuals

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
27 (actual)
Sponsor
Medical University of South Carolina · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

In summary, this pilot study will explore the use of an innovative pharmacologic approach to the treatment of substance dependence through the facilitation of extinction of response to cocaine-conditioned cues in cocaine-dependent individuals. If DCS proves successful in this preliminary study, a controlled treatment trial will be planned. This novel approach could have implications for the treatment of multiple substance use disorders including methamphetamine, marijuana and opiate dependence.

Detailed description

Cocaine dependence remains a serious problem in the US today and in spite of two decades of intense research, efficacious pharmacotherapeutic treatments have not been identified. Cocaine-associated environmental cues can elicit drug craving and exposure to cocaine-related cues is likely to be involved in relapse. Emerging data supports the role of glutamate in extinction of associative learning in animal models of rear-conditioning and clinical studies of exposure treatment for anxiety disorders. A recent study demonstrated DCS acceleration of cocaine-induced conditioned place preference in rats. Exploration of DCS in facilitating extinction of response to drug-related cues in humans is needed. The proposed study will extend these innovative and promising findings from the basic science arena and anxiety disorders field in a proof of concept investigation of DCS facilitation of extinction of response to cocaine-related cues in a human laboratory paradigm.

Conditions

Interventions

TypeNameDescription
DRUGD-cycloserine50 mg DCS
DRUGPlaceboPlacebo

Timeline

Start date
2006-09-01
Primary completion
2008-07-01
Completion
2008-07-01
First posted
2008-10-27
Last updated
2018-07-06
Results posted
2018-07-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00780442. Inclusion in this directory is not an endorsement.